Showing results (111-120 of 191) with videos related to

Sort By:
Pageof 20
JPGN Reports|May 19, 2025
SPNing our wheels-Pancreatic solid pseudopapillary neoplasm as an extraluminal etiology of persistent duodenal ulcerationKanak V Kennedy, Jibraan A Fawad, Y Dana Neugut, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 19, 2020
North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on Entrustable Professional Activities: Development of Pediatric Gastroenterology, Hepatology, and Nutrition Entrustable Professional ActivitiesCary G Sauer, Jacob Robson, Yumirle P Turmelle, et al.
Nature Communications|January 16, 2024
NAD<sup>+</sup> dependent UPR<sup>mt</sup> activation underlies intestinal aging caused by mitochondrial DNA mutationsLiang Yang, Zifeng Ruan, Xiaobing Lin, et al.
Gastroenterology|June 8, 2020
Impaired Redox and Protein Homeostasis as Risk Factors and Therapeutic Targets in Toxin-Induced Biliary AtresiaXiao Zhao, Kristin Lorent, Diana Escobar-Zarate, et al.
Hepatology (Baltimore, Md.)|November 26, 2008
Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotypeMatthew J Ryan, Christina Bales, Anthony Nelson, et al.
Human Mutation|May 4, 2010
Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosisRobert C Bauer, Ayanna O Laney, Rosemarie Smith, et al.
Pediatric Transplantation|July 26, 2019
Barriers to ideal outcomes after pediatric liver transplantationVicky Lee Ng, George V Mazariegos, Beau Kelly, et al.
Plos Genetics|August 14, 2018
A genome-wide association study identifies a susceptibility locus for biliary atresia on 2p16.1 within the gene EFEMP1Ying Chen, Melissa A Gilbert, Christopher M Grochowski, et al.
NPJ Regenerative Medicine|January 6, 2018
Intraoperative delivery of the Notch ligand Jagged-1 regenerates appendicular and craniofacial bone defectsDaniel W Youngstrom, Rafael Senos, Robert L Zondervan, et al.
Journal of Medicinal Chemistry|March 25, 2022
Structure-Based Discovery and Optimization of Furo[3,2-<i>c</i>]pyridin-4(5<i>H</i>)-one Derivatives as Potent and Second Bromodomain (BD2)-Selective Bromo and Extra Terminal Domain (BET) InhibitorsJunhua Li, Cheng Zhang, Hongrui Xu, et al.
Pageof 20